Cargando…
Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia
BACKGROUND: Aggressive natural killer cell leukemia is a devastating disease, with an average patient survival time of less than 2 months following diagnosis. Due to P-glycoprotein-mediated resistance of the tumor cells most forms of chemotherapy are of limited efficacy, therefore new treatment stra...
Autores principales: | Henslee, Austin B., Steele, Timothy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085711/ https://www.ncbi.nlm.nih.gov/pubmed/30116531 http://dx.doi.org/10.1186/s40364-018-0140-0 |
Ejemplares similares
-
Statins inhibit proliferation and cytotoxicity of a human leukemic natural killer cell line
por: Crosbie, Jon, et al.
Publicado: (2013) -
Aggressive natural killer cell leukemia: a case report
por: Hu, Ying, et al.
Publicado: (2017) -
Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge
por: You, Eunkyoung, et al.
Publicado: (2023) -
A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient
por: Donato, Umberto M, et al.
Publicado: (2022) -
Long Complete Remission Achieved with the Combination Therapy of Cisplatin and Gemcitabine in a Patient with Aggressive Natural Killer Cell Leukemia
por: LaPorte, Justin, et al.
Publicado: (2015)